Accelerated clinical biomarker prediction (acbp) platform

A non-transitory computer-readable medium storing instructions, the instructions comprising:

• one or more instructions that, when executed by one or more processors, cause the one or more processors to:
• receive medical data associated with potential patients for a clinical trial of a drug,
• the medical data including at least two of:
• multi-omics data associated with the potential patients,
• genomic profiles of the potential patients,
• dosage and time associated with the drug,
• electronic medical records of the potential patients, or
• clinical trial data associated with the drug;
• perform a topological data analysis, a non-matrix factorization analysis, and a neural network analysis of the medical data,
• at least two of the topological data analysis, the non-matrix factorization analysis, or the neural network analysis of the medical data to be performed in parallel;
• identify a group of patients, of the potential patients, for the clinical trial of the drug,
• the group of patients being identified based on consensus results generated by performing the topological data analysis, the non-matrix factorization analysis, and the neural network analysis of the medical data;
• and
• provide information identifying the group of patients.

A method, comprising:

• receiving, by a device, medical data associated with potential patients for a clinical trial of a drug,
• the medical data including one or more of:
• multi-omics data associated with the potential patients,
• genomic profiles of the potential patients,
• dosage and time associated with the drug,
• electronic medical records of the potential patients, or
• clinical trial data associated with the drug;
• preprocessing, by the device, the medical data to generate normalized and dimensionally reduced medical data;
• performing, by the device and in parallel, a topological data analysis, a non-matrix factorization analysis, and a neural network analysis of the normalized and dimensionally reduced medical data;
• identifying, by the device, a group of patients, of the potential patients, for the clinical trial of the drug based on performing the topological data analysis, the non-matrix factorization analysis, and the neural network analysis of the normalized and dimensionally reduced medical data;
• and
• providing, by the device, information identifying the group of patients.